CompanyTrack
K

KLEIDOX THERAPEUTICS LTD

Active Oxford

Research and experimental development on biotechnology

0 employees
Research and experimental development on biotechnology
K

KLEIDOX THERAPEUTICS LTD

Research and experimental development on biotechnology

Founded 5 Nov 2020 Active Oxford, England 0 employees
Research and experimental development on biotechnology
Accounts Submitted 22 Nov 2024
Confirmation Statement Submitted 4 Nov 2025
Net assets £1.00 £0.00 2024 year on year
Total assets £0.00
Total Liabilities £0.00
Charges None No charges registered

AI Analysis

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Registered Address

Hayakawa Building, Edmund Halley Road Oxford OX4 4GB England

Credit Report

Discover KLEIDOX THERAPEUTICS LTD's Credit Score, limit, and payment likelihood.

Mutual Companies

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2023–2024)

Cash in Bank

N/A

Net Assets

£1.00

Total Liabilities

N/A

Turnover

N/A

Employees

N/A

Debt Ratio

N/A

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

1 Allotment 2,125 Shares £451.563 Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
18 Dec 20202,125£451.563£0.213

Officers

Officers

2 active 6 resigned
Status
Alastair Graham MackinnonDirectorBritishEngland559 Feb 2024Active
Emma SmithDirectorBritishUnited Kingdom409 Feb 2024Active

Shareholders

Shareholders (1)

Dark Blue Therapeutics Ltd
100.0%
10,0005 Nov 2021

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Dark Blue Therapeutics Ltd

United Kingdom

Active
Notified 5 Nov 2020
Nature of Control
  • Ownership Of Shares 75 To 100 Percent
  • Voting Rights 75 To 100 Percent
  • Right To Appoint And Remove Directors

Group Structure

Group Structure

DARK BLUE THERAPEUTICS LTD united kingdom shares 25 to 50 percent, voting rights 25 to 50 percent
BMS STRATEGIC PORTFOLIO INVESTMENTS HOLDINGS, INC. united states of america
KLEIDOX THERAPEUTICS LTD Current Company

Charges

Charges

No charges registered

Documents

Company Filings

DateCategoryDescriptionDocument
4 Nov 2025Confirmation StatementConfirmation statement made on 2025-11-04 with no updatesView(3 pages)
22 Nov 2024AccountsAnnual accounts made up to 2024-06-30View(4 pages)
11 Nov 2024Confirmation StatementConfirmation statement made on 2024-11-04 with updatesView(4 pages)
19 Feb 2024AccountsAnnual accounts made up to 2023-06-30View(4 pages)
12 Feb 2024OfficersTermination of Thomas Hanke as director on 2024-02-09View(1 page)
4 Nov 2025 Confirmation Statement

Confirmation statement made on 2025-11-04 with no updates

22 Nov 2024 Accounts

Annual accounts made up to 2024-06-30

11 Nov 2024 Confirmation Statement

Confirmation statement made on 2024-11-04 with updates

19 Feb 2024 Accounts

Annual accounts made up to 2023-06-30

12 Feb 2024 Officers

Termination of Thomas Hanke as director on 2024-02-09

Recent Activity

Latest Activity

Confirmation statement made on 2025-11-04 with no updates

3 months ago on 4 Nov 2025

Annual accounts made up to 2024-06-30

1 years ago on 22 Nov 2024

Confirmation statement made on 2024-11-04 with updates

1 years ago on 11 Nov 2024

Annual accounts made up to 2023-06-30

1 years ago on 19 Feb 2024

Termination of Thomas Hanke as director on 2024-02-09

2 years ago on 12 Feb 2024